News

By using Oracle Health Sciences Network, Joslin joins a growing list of healthcare provider participants which will expand clinical trial research for its patients through real-time collaboration with

The deal is initially aimed at using the companies’ complementary scientific platforms within the framework of ongoing research projects. Both the firms will assess results achieved to date,

The deal will combine integrated components to allow clinicians to use genomic data generated by laboratories more easily and efficiently to discover targeted therapeutic options suitable for each

The company will use the funding to advance its second clinical program with a new TCR to enter the clinic in the UK. Biomedical Catalyst Fund’s £2.1m grant

Launched in January 2008 for secondary hyperparathyroidism (HPT) in patients who are undergoing regular dialysis, Regpara tablets 25mg and 75mg acts on calcium receptors on the parathyroid gland

Based on the National Eye Institute’s Age-Related Eye Disease Studies (AREDS and AREDS2), AREDS2 Silver supplies antioxidants for macular health without the high levels of zinc that may

In April 2013, Valeant offered Actavis the rights to Metronidazole 1.3%, which provides a convenient, single-dose treatment for BV. BV is an infection caused by an imbalance in

The products include prescription drugs to treat patients undergoing ocular interventions or suffering from infections or inflammatory diseases of the eye. In particular, the portfolio includes two artificial

This method of use patent covers the company’s Brisdelle (paroxetine) capsules, 7.5mg, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to